Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.
暂无分享,去创建一个
Reshma Jagsi | Monica Morrow | Kevin C Ward | Allison W Kurian | Steven J Katz | R. Jagsi | M. Morrow | S. Hawley | A. Kurian | K. Ward | A. Hamilton | S. Katz | Sarah T Hawley | Ann S Hamilton | L. Wallner | Lauren P Wallner | M Chandler Mcleod | M. C. McLeod
[1] Angela P. Wetzel. Internet, mail, and mixed‐mode surveys: The tailored design method , 2010 .
[2] E. Port,et al. Genetic Testing in Patients With Newly Diagnosed Breast Cancer: Room for Improvement. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Loi,et al. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. , 2017, New England Journal of Medicine.
[4] Jane C Weeks,et al. Physicians' attitudes about multiplex tumor genomic testing. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] K. Hughes,et al. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. Jagsi,et al. Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer , 2017, JAMA.
[7] K. Offit,et al. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] E. V. Van Allen. The Potential and Challenges of Expanded Germline Testing in Clinical Oncology. , 2017, JAMA.
[9] C. Childers,et al. National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] R. Jagsi,et al. Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Garber,et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Kenneth Offit,et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.
[13] P. Kantoff,et al. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing , 2017, JAMA.
[14] S. Hawley,et al. Treatment experiences of Latinas after diagnosis of breast cancer , 2017, Cancer.
[15] M. Robson,et al. American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. , 2010, Journal of Clinical Oncology.
[16] K. Hughes. Genetic Testing: What Problem Are We Trying to Solve? , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] R. Pollock,et al. Breast Cancer Genetic Counseling: A Surgeon’s Perspective , 2016, Front. Surg..
[18] N. Aaronson,et al. Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial , 2015, Genetics in Medicine.
[19] M. Ballinger,et al. Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review , 2017, Clinical genetics.
[20] S. Friedman,et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.
[21] N. Aaronson,et al. Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial , 2014, British Journal of Cancer.